about Us

The Pediatric Acute Lung Injury and Sepsis Investigators Network (PALISI Network) specializes in identifying preventive, therapeutic, and preventive strategies for acute respiratory distress syndrome, sepsis, multi-organ failure, and other acute, life-threatening pulmonary or systemic inflammatory syndromes that affect infants and children. PALISI was founded in 2002 by Adrienne Randolph. Since its inception, it has grown to over 400 members. PALISI Network meets twice annually in March and September. The Pediatric Acute Lung Injury and Sepsis Investigators Network (PALISI Network) specializes in identifying preventive, therapeutic, and preventive strategies for acute respiratory distress syndrome, sepsis, multi-organ failure, and other acute, 

PALISI Executive Committee

PALISI Scientific Steering Committee

Past Executive Committee Chairs

PALISI History

The Pediatric Acute Lung Injury and Sepsis Investigators Network (PALISI Network) specializes in identifying preventive, therapeutic, and preventive strategies for acute respiratory distress syndrome, sepsis, multi-organ failure, and other acute, life-threatening pulmonary or systemic inflammatory syndromes that affect infants and children. PALISI was founded in 2002 by Adrienne Randolph. Since its inception, it has grown to over 400 members. PALISI Network meets twice annually in March and September. The Pediatric Acute Lung Injury and Sepsis Investigators Network (PALISI Network) specializes in identifying preventive, therapeutic, and preventive strategies for acute respiratory distress syndrome, sepsis, multi-organ failure, and other acute, 

Collaboration

 

Clinical researchers from 90+ pediatric ICUs across North America and beyond collaborate in PALISI.

 

Research Design

 

Multi-center research studies of disease processes, interventions, and outcomes in children’s critical care.

Prospective Studies

 

Prospective cohort, case-control, genetic epidemiology, and gene expression, drug dosing and metabolism studies, and Phase I, II, III, and IV clinical trials.

 

Optimizing Clinical Care

 

Network collaborations with the ultimate goal of improving the care and health outcomes of critically ill infants and children throughout the world.